Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects
Florenzo Iannone, Francesco Trotta, Carlomaurizio Monteccuco, Roberto Giacomelli, Mauro Galeazzi, Marco Matucci-Cerinic, Clodoveo Ferri, Maurizio Cutolo, Lisa Maria Bambara, Giovanni Triolo, Gianfranco Ferraccioli, Gabriele Valentini, Giovanni Lapadula
Annals of the Rheumatic Diseases Feb 2007, 66 (2) 249-252; DOI: 10.1136/ard.2006.058776